Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
09/03/2008 | CN100415673C Use of phosphorus-oxygen acid esters containing alkoxy groups as corrosion inhibitors for reinforced concrete |
09/02/2008 | US7420081 Methods for synthesizing phosphonic compounds and compounds thereof |
09/02/2008 | US7420074 Process for fluoro derivative-substituted aryl pnictogens and their oxides |
09/02/2008 | US7420070 Resolution with acid; salt formation, cyclization |
09/02/2008 | US7420007 Including the telomers: ethylbutylphospinic salts, butylbutylphosphinic salts, ethylhexylphosphinic salts, butylhexylphosphinic salts, or hexylhexylphosphinic salts; flame-retardant polymer molding materials |
09/02/2008 | US7420000 e.g. 2-((Diethoxvphosphoryl)methylamino)-2-(furan-2-yl)acetic acid; antiinflammatory, antiproliferative agent, viricide, parasiticide; autoimmune, cardiovascular, bone resorption diseases; one-step three-component reaction among amine derivative, carbonyl derivative and organoboron compound |
09/02/2008 | US7419973 Phosphonocephem compound |
09/02/2008 | US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide |
09/02/2008 | US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
09/02/2008 | CA2386813C Bicyclic imidazo-3-yl amine derivatives substituted on the 6-membered ring |
09/02/2008 | CA2314238C Synthesis of combretastatin a-4 prodrugs and trans-isomers thereof |
09/02/2008 | CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors |
08/28/2008 | WO2008103707A1 Mono-and di-phosphates of 3-(3-fluoro-4-hydroxy-phenyl)-7-hydroxy-naphthalene-1-carbonitrile |
08/28/2008 | WO2008103415A2 Methods of preparing phosphoric acids of combretastatin and derivatives thereof |
08/28/2008 | WO2008101881A2 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof |
08/28/2008 | WO2008030115A3 Fluorescent cell markers |
08/28/2008 | US20080207942 Using in coordination catalyst containing transition metal for hydrogenation, phase transfer, cyanation,borating, hydrosilylation |
08/28/2008 | US20080207913 Etherification of biological active materials |
08/28/2008 | US20080207887 oligonucleotide probes; dye attached to probe by electrophilic group consisting of pentafluorophenyl esters and N-hydroxysuccinimide esters |
08/28/2008 | US20080207776 Lipid aggregate for delivery of macromolecules into cells |
08/28/2008 | US20080207568 Class of Gamma Delta T Cells Activators and Use Thereof |
08/28/2008 | US20080207564 Derivaitves of 4-Or 5-Aminosalicylic Acid |
08/28/2008 | US20080207554 Oligonucleotides with phosphotriester linkages; ribonuclease L activators; antineoplastic agents, namely against leukemias, viricides, parasiticides for Chagas' Disease; nucleotide chemical synthesis |
08/28/2008 | US20080207490 Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications |
08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
08/28/2008 | US20080206151 Magnetic resonance imaging (MRI) contrast agent; synthesis by reacting acid-functional group with phosphoethanolamine and then with a peptide; amine containing phospholipids with functional groups in the liposome membrane that are useful as sites for binding |
08/27/2008 | EP1961757A1 Phosphoindoles as HIV inhibitors |
08/27/2008 | EP1961734A1 Amine compound and use thereof for medical purposes |
08/27/2008 | EP1961416A1 Medical use of inhibitors of glutaminyl and glutamate cyclases |
08/27/2008 | EP1960409A2 Tetraphosphorus ligands for catalytic hydroformylation and related reactions |
08/27/2008 | EP1960057A1 Surface active calcium phosphates |
08/27/2008 | EP1644430B1 Method for producing phosphonate-modified silicones |
08/27/2008 | EP1581474B1 Chiral arylketones in the treatement of neutrophil-dependent inflammatory deseases |
08/27/2008 | EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
08/27/2008 | CN101253184A Phosphorus compound, use thereof and flame-retardant polyester fiber |
08/27/2008 | CN101253183A Process for preparing optically active diphosphanes |
08/27/2008 | CN101250200A Method for synthesizing bis-(2,4-di-tert-butyl phenyl) pentaerythritol diphosphite |
08/27/2008 | CN101250199A Method for preparing diisopropyl phosphite |
08/27/2008 | CN101250198A Method for synthesizing phosphoenolpyruvate potassium pyruvate salt |
08/27/2008 | CN100413873C Ion type liquid |
08/27/2008 | CN100413508C Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
08/26/2008 | US7417164 Fluorescent dyes, including 8-hydroxypyrene-1,3,6-trislfonic acid (HPTS) and its derivatives; useful for analyte detection, determining blood glucose concentration |
08/26/2008 | US7417065 Therapy, prevention of lymphocyte causing disease; antiinflammatory agents; autoimmune disease |
08/26/2008 | US7417057 insecticides; safe for crops; Fused partially unsaturated carbocyclic or heterocyclic ring substituted with a 5-or 6-membered heterocyclic ring such as imidazole, thiazole, oxazole, 1,3,4-oxadiazole |
08/26/2008 | US7417055 Pharmacokinetics; bioavailability |
08/26/2008 | US7417036 adding organic solvent and dissolivng adefovir dipivoxil ultrasonically to form solution, and spray drying; have different melting points, solubility, and density |
08/26/2008 | US7417035 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
08/26/2008 | US7416898 Derived from the oxidation of novel alkenes prepared by the coupling of substituted aromatic esters or ketones and spiro-fused ketones with or without a pi -electron system or a carbon-carbon double bond in the ring |
08/26/2008 | CA2397961C Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors |
08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
08/21/2008 | WO2008101147A2 Methods and compositions for regulating bone mineral density |
08/21/2008 | WO2008100316A1 Phosphate-containing flame retardants |
08/21/2008 | WO2008099203A2 Reactions of isotopically enriched elements of phosphorus, sulfur, selenium and tellurium |
08/21/2008 | WO2008098375A1 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
08/21/2008 | WO2008098304A1 Carborane-phosphonium compounds and their use in boron neutron capture therapy and imaging |
08/21/2008 | WO2008076269A3 MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS |
08/21/2008 | WO2006020947A3 Phosphonate fluorescent dyes and conjugates |
08/21/2008 | US20080200744 Trimerisation and oligomerisation of olefins using a chromium based catalyst |
08/21/2008 | US20080200729 Using an organophosphine compound in presence of catalyst, base, ligand and iodine cocatalyst |
08/21/2008 | US20080200695 Complex catalyst which contains noval ligand system and transition metal |
08/21/2008 | US20080200683 Process for Preparing (Alpha S, Beta R)-6-Bromo-Alpha-[2-(Dimethylamino) Ethyl]-2-Methoxy-Alpha-1-Naphthalenyl-Beta-Phenyl-3-Quinolineethanol |
08/21/2008 | US20080200679 Addition of a Grignard reagent or organoindium compound to tetraalkyl carbonylbisphosphonate or trialkyl carbonylbisphosphonacetate |
08/21/2008 | US20080200437 Polyphosphorylated inositol derivatives; allosteric effectors, cell signaling molecule analogs; hypoxia related diseases |
08/21/2008 | US20080200425 Methods and compositions for regulating bone mineral density |
08/21/2008 | US20080200371 Thiazole and thiadiazole inhibitors of tyrosine phosphatases |
08/21/2008 | US20080199731 Use of a Copper (I) Complexes For Organic Luminescent Diodes |
08/21/2008 | US20080199454 Caspase inhibitor prodrugs |
08/20/2008 | EP1958952A1 Ionic compounds |
08/20/2008 | EP1958951A1 Phosphine transition metal complex, method for producing same and antitumor agent containing same |
08/20/2008 | EP1958950A1 Process for the preparation of dialkylphosphinic acid salts |
08/20/2008 | EP1957509A2 Methods and compositions for the treatment of gastrointestinal disorders |
08/20/2008 | EP1735324B1 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis |
08/20/2008 | EP1603927B1 Optically detectable (alkylacyl-2-aminodesoxy-glycero)-nitrophenyl-phosphonates |
08/20/2008 | CN101248142A Red-shifted water-dispersible naphthalocyanine dyes |
08/20/2008 | CN101248082A Stable water soluble composition containing lysophosphatidylethanolamine and lecithin |
08/20/2008 | CN101248069A Androgen receptor modulators and method of treating disease using the same |
08/20/2008 | CN100412162C Dicyclic phosphonate fire retardant synthesis method |
08/20/2008 | CN100412081C Cobait dipenta cation diphosphine ligand preparation and application thereof |
08/20/2008 | CN100412079C Process for production of phosphine-borane complexes |
08/20/2008 | CN100412078C Fluorine substituted phenoxy acetyl oxide alkyl phosphonate ester and salt with weeding active and preparation process thereof |
08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
08/19/2008 | US7414156 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation |
08/19/2008 | US7414155 catalyst system which includes a source of Group VIII metal cations; a diphosphine ligand |
08/19/2008 | US7414151 Process for manufacture of 4-amino-hydroxybutylidene-1, 1-bisphosphonic acid and its salts |
08/19/2008 | US7414076 Methods and compositions for treating amyloid-related diseases |
08/19/2008 | US7414056 Cytokine inflammatory response suppressors; mitogen activated protein 38 kinases |
08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
08/19/2008 | US7414040 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia |
08/19/2008 | CA2257448C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
08/19/2008 | CA2151801C 3'-modified oligonucleotide derivatives |
08/14/2008 | WO2008097674A1 Crosslinkers containing phosphorous |
08/14/2008 | WO2008097483A2 Methods for preparing aryl-substituted ketophosphonates |
08/14/2008 | WO2008096002A1 Hcv inhibiting macrocyclic phosphonates and amidophosphates |
08/14/2008 | WO2008095678A1 Process for the preparation of optically active 2-amino-1-phenylethanols |
08/14/2008 | WO2008051584A3 Process for the preparation of highly purified, dialkydithiophosphinic compounds |
08/14/2008 | WO2008033246A3 Zwitterionic group viii transition metal initiators supported by olefin ligands |
08/14/2008 | US20080194886 Catalysts for nucleophilic substitution, synthesis thereof, composition containing them and use thereof |
08/14/2008 | US20080194853 Novel Iridium Complex and Organic Electroluminescence Device Using the Same |
08/14/2008 | US20080194843 for polymerizing a film-forming resin having a pendant phosphate or phosphonate or phosphinate group and a crosslinkable group; the phosphorous coordinates metals via covalently bonded oxygen atoms; metals are from substrate surface or in the form of metal catalysts; fewer steps and improved adhesion |
08/14/2008 | US20080194831 anion is bis(pentafluoroethyl)phosphinic imide [(C2F5)2P(O)]2N- ; solvents for electrochemical reactions; salt formation |